Open access
Open access
Powered by Google Translator Translator

[Preprint] Practice Changing RCT: Therapeutic-dose anticoagulation with heparin (LMWH or unfractionated heparin) improves outcomes in non-critically ill patients with Covid-19 – the superiority of therapeutic-dose anticoagulation was seen in both high and low D-dimer groups.

18 May, 2021 | 08:04h | UTC

Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19 – medRxiv

Related: [Preprint] RCT: Full-dose/therapeutic anticoagulation provides no benefit in critically ill patients with Covid-19


Commentary on Twitter


Stay Updated in Your Specialty

No spam, just news.